ABOUT

us

The idea of creating Cerebrum Matter stems from our founder’s personal experience of accompanying her grandmother through a rough journey with Parkinson’s, a decade ago.

Our idea of digital healthcare came to the fore in 2016 when the company’s bootstrapping stage, leading to the idea of a therapy software highly focused on dementia symptoms. The development of the software tunnelled into the R&D process by end of 2017, leading us to start working on conducting a clinical trial with people to develop an evidence-based product aiming sincerely at treating cognitive declination, depression, anger & anxiety, the logical reasoning which are considered to leading onset symptoms of dementia using brainwave analysis.

Dementia is the broad category of neurodegenerative brain diseases that includes such diseases as Alzheimer’s, vascular dementia and Lewy body dementia, etc. 

While the use of medication is undoubtedly vital in helping both severe and light sufferers of dementia, Cerebrum Matter believes that dementia prevention is still an underdeveloped form of treatment that could potentially change the way the earlier stages of dementia are treated.

With our advanced brainwave technology we are aiming to provide a personalised experience of cognitive improvement according to each individuals’ brain functionalities.

Changing the Game for Healthy

Ageing

Our Timelines

Cerebrum Matter Founded
2015

COSMA development + Clinical trials
2018

COSMA Soft Launch
2020

Neurofeedback Europe Launch
2021

Cerebrum Matter Active
2017
Neurofeedback Headset Development
2019
Neurofeedback CE Approved
2021

Mission

To prevent and reduce the prevalence of the symptoms of early onset dementia, by promoting mental wellness and thus leading to longer and higher quality independent lives to the elderly.

Vision

To become a Global leader in the field of cognitive therapy focused brainwave technology, leading to a significant reduction in the estimated numbers of future potential victims of dementia.

Meet the Team

KARTHEKA BOJAN

KARTHEKA BOJAN

CEO

Miss Kartheka Bojan, Founder & CEO of Cerebrum Matter Ltd, a digital healthcare
Miss Kartheka Bojan, Founder & CEO of Cerebrum Matter Ltd, a digital healthcare start-up working on early dementia. She holds an MSc in Biomedical Engineering from the University of Nottingham. After working at IBM India, she spent 5 years in the UK developing medical devices. She has an entrepreneurial spirit and a Visionary.

In her role as Chief Medical Engineer at her previous employment, she designed a Nanotechnology-based Non-Invasive Continuous Glucose Monitoring Device. She is the author of pending patents in EEG technology for Alzheimer’s & a Glucose Monitoring device and has also published work on Design of Biosensors with Gold Nanoparticles.

The idea of creating Cerebrum Matter stems from her personal experience of accompanying her grandmother through a rough journey with Parkinson’s, a decade ago. Her vision to treat early onset dementia through digital therapy has been transformed into Cerebrum Matter’s mission to reduce the prevalence of disabling symptoms for people living with dementia.

ANDREW PERKINS

ANDREW PERKINS

CFO

Andrew Perkins has 10 years’ experience in the finance sector and a certified accountant
Andrew Perkins has 10 years’ experience in the finance sector and a certified accountant. He has well-established experience with start-up companies and has been responsible for closing several seeds to series A rounds. His finance skillset includes setting up financial models for start-ups with a focus on scalable controls.

Andrews core values are based on accountability and integrity with an entrepreneurial, strategic focus.
Driving growth at a digital asset exchange while ensuring a focus on revenue-generating products through implementing robust forecasting capability. Ensuring a culture of control and improving management information.

MOHAMED MAHER

MOHAMED MAHER

CCO

Mohamed has been involved in starting and running several businesses,
Mohamed has been involved in starting and running several businesses, developing new business relationships with clients, channel sales partners, funders and government bodies. He is passionate about healthcare technology and the need to empower communities and engage them with healthcare systems using simple and intuitive mobile health solutions.

Through his position as the managing director of Balsamee, Mohamed has got involved in several R&D initiatives that spur the influence of digital health technology in improving patient treatment outcomes by disrupting the ways healthcare is being practised and enabling more efficient service delivery.

David Clarkson MBA

David Clarkson MBA

Sales Director

David focuses on helping clients identify opportunities to improve performance
David focuses on helping clients identify opportunities to improve performance and realise benefits, through the use of technology. This includes helping clients adapt to new demands and new industry models.

In healthcare, he has applied this experience to exploring how clinicians, care providers and commissioners can adapt operating models and use innovation and technology to enable better and more cost-effective care. Examples of this include Digital Hospital technologies, Virtual Assistants (chatbots), remote (home) monitoring and applying analytics to help outcomes, performance and efficiencies.

David is a very experienced relationship manager, with deep industry knowledge, who is committed to client satisfaction and achieving success for both parties.

PROF.Elizabeta Mukaetova-Ladinska

PROF.Elizabeta Mukaetova-Ladinska

CLINICAL ADVISOR

Prof. Mukaetova-Ladinska is chairman of Old Age Psychiatry, University of Leicester
Prof. Mukaetova-Ladinska is chairman of Old Age Psychiatry, University of Leicester, and clinician at Leicestershire Partnership Trust (LPT). She is the clinical advisor of Cerebrum Matter Ltd. She is the clinical lead for validating the CM’s COSMA Software in collaboration with University of Leicester. Her areas of academic interest include developing biomarkers with high sensitivity and specificity to detect various forms of dementia and their implementation in the routine clinical setting to monitor the progression of the disease and treatment.

Dr Elizabeta Mukaetova-Ladinska is the lead investigator on an Alzheimer’s Society-funded study, entitled ‘Blood Markers in Dementia Study’. The potential outcome would be to develop an inexpensive yet accurate test that could differentiate between Alzheimer’s disease and other forms of dementia, such as dementia with Lewy bodies and vascular dementia.

ADNAN ASHFAQ

ADNAN ASHFAQ

REGULATORY DIRECTOR

Adnan is the Quality, Regulatory & Validation Specialist with over 19 years of exp
Adnan is the Quality, Regulatory & Validation Specialist with over 19 years of experience in Medical Device, Biotech and Pharmaceutical industries. Adnan’s validation experience includes, Building facilities, packaging, bottling, labelling, software, water, utilities, equipment, protocol preparation, execution, man management, validation plan, policy write ups, contractor management full facility validation, training roll out in several companies.

His expertise is more towards Medical Device regulations and Pharma Industry. He is well updated with all the MDR and new regulatory policies both in Europe and USA. Adnan is responsible for all the regulatory pathway and direction of CM’s all products.

Ramana Tadepalli

Ramana Tadepalli

Strategic Advisor

Ramana is the Founder and President of California USA based 3S Ventures;
Ramana is the Founder and President of California USA based 3S Ventures; a Venture Capital and business consulting company with expertise in Medical Technologies, Biotech, Pharma, Precision Medicine, Artificial Intelligence (AI) and Blockchain in healthcare and Infrastructure.

Ramana has access to experts and senior leaders in the industry in USA, Europe, Middle East, India and Latin America. Many of these experts are formal consulting partners of 3S Ventures.

Ramana is a partner at Bridege4Bio, a California based consulting company that is involved in product development and global commercialization of Life Science products. Ramana is advisor and associate at One Rock Capital Partners, Ramana is also associated with Shoreview Capital, a St.Paul/ Minneapolis USA based Private Equity Fund and advices on Healthcare acquisitions.

Thierry Lambert

Thierry Lambert

Marketing & Sales Advisor

Thierry has a wealth of experience in business development, sales and
Thierry has a wealth of experience in business development, sales and marketing across the life sciences industry in Europe, Middle-East, US, as well as Latin America and Asia.

He is a skilled leader with the ability to create teams to improve performance, accomplish defined goals, and achieve beyond expectations. Possessing the qualities to deliver hands-on leadership, analytical, and critical decision-making skills with a commitment to work with integrity, positivity, and quality with both internal and external partners.

Robert Hehakaya

Robert Hehakaya

Business Development Advisor

As a seasoned executive with over 25 years of international industry experience
As a seasoned executive with over 25 years of international industry experience, Robert has developed his expertise in a variety of roles ranging from consulting to operational management with an emphasis on strategy & transformation, sales & marketing, mergers & acquisitions, innovation and operational excellence.
 
After a global tenure at IBM he has been involved in a number of start-ups and innovation programs, The emerging Blockchain technology, AI & Robotica have caught his interest as the next game changers in building sustainable businesses with societal impact.
Steven Wakefield

Steven Wakefield

Marketing Advisor & Board Observer

Steven has worked with major organizations worldwide for over forty years.
Steven has worked with major organizations worldwide for over forty years. This has been from a consultancy, technical and commercial perspective.

Steven’s roles have involved working with all types of business in identifying future trends and preparing their operations for the upcoming business challenges. Steven began a very successful sales career in 1984 leading to Managing Director roles running multi-million-pound organizations in the United Kingdom and the Middle East.

As a Management Consultant Steven has appeared on numerous panels and has spoken on many business topics in Europe, the Middle East, Africa and Asia. Steven is now a professional Business Advisor working with organisations all over the United Kingdom.